AstraZeneca unveils drug to treat mutating breast cancer before growth

AstraZeneca unveils drug to treat mutating breast cancer before growth

FT.com

Published

Pharma group estimates Camizestrant could be worth up to $5bn of sales in its peak year

Full Article